DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapy

Chemo-dynamic therapy (CDT) has a great potential in tumor extirpation. It entails producing hypertoxic reactive oxygen species (ROS) that damage the DNA of tumor cells and other biomacromolecules. However, the efficiency of CDT is severely hampered by the massive presence of glutathione (GSH) in tu...

Full description

Saved in:
Bibliographic Details
Main Authors: Cui Ren, Zhiyong Shi, Xiaowen Zhang, Xueer Yu, Yang Gao, Zhi Qi, Yu Chen, Yong Wang
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2025-03-01
Series:Bioactive Materials
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2452199X24004936
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586257782276096
author Cui Ren
Zhiyong Shi
Xiaowen Zhang
Xueer Yu
Yang Gao
Zhi Qi
Yu Chen
Yong Wang
author_facet Cui Ren
Zhiyong Shi
Xiaowen Zhang
Xueer Yu
Yang Gao
Zhi Qi
Yu Chen
Yong Wang
author_sort Cui Ren
collection DOAJ
description Chemo-dynamic therapy (CDT) has a great potential in tumor extirpation. It entails producing hypertoxic reactive oxygen species (ROS) that damage the DNA of tumor cells and other biomacromolecules. However, the efficiency of CDT is severely hampered by the massive presence of glutathione (GSH) in tumor cells and the interference of ROS defense systems, such as Mutt homolog 1 (MTH1) protein sanitizes ROS-oxidized nucleotide pools. In this research, DNA-mediated self-assembly nanoparticles (HTCG@TA NPs) were engineered with high-performance amplified oxidative damage and gene therapy effect for synergistic anti-tumor treatment. Cu2+ was converted into Cu + by redox reactions to deplete GSH while H2O2 was catalyzed to generate hydroxyl radicals (·OH). As a result, the ROS level was evidently improved. Moreover, controllable-released TH588 prevented MTH1-mediated DNA repairing, thus aggravated oxidative damage to tumor cells. Meanwhile, the released functional nucleic acid G3139 downregulated the expression of Bcl-2, and accelerated the apoptosis of tumor cells. In conclusion, the HTCG@TA demonstrated significant effect in oxidative damage amplification and tumor inhibition both in vitro and in vivo, which has provided a new outlook for the clinical application of chemo-dynamic tumor treatment and synergistic gene therapy with self-delivery nanoplatforms.
format Article
id doaj-art-4d38775086614db5b81b131655587eb0
institution Kabale University
issn 2452-199X
language English
publishDate 2025-03-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Bioactive Materials
spelling doaj-art-4d38775086614db5b81b131655587eb02025-01-26T05:04:20ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2025-03-0145434445DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapyCui Ren0Zhiyong Shi1Xiaowen Zhang2Xueer Yu3Yang Gao4Zhi Qi5Yu Chen6Yong Wang7Department of Chemistry, School of Science, Tianjin University, Tianjin, 300072, ChinaDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, ChinaDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, ChinaSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, ChinaDepartment of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China; Corresponding author.Department of Molecular Pharmacology, School of Medicine, Nankai University, Tianjin, 300071, China; Corresponding author.Department of Chemistry, School of Science, Tianjin University, Tianjin, 300072, China; Corresponding author.Department of Chemistry, School of Science, Tianjin University, Tianjin, 300072, ChinaChemo-dynamic therapy (CDT) has a great potential in tumor extirpation. It entails producing hypertoxic reactive oxygen species (ROS) that damage the DNA of tumor cells and other biomacromolecules. However, the efficiency of CDT is severely hampered by the massive presence of glutathione (GSH) in tumor cells and the interference of ROS defense systems, such as Mutt homolog 1 (MTH1) protein sanitizes ROS-oxidized nucleotide pools. In this research, DNA-mediated self-assembly nanoparticles (HTCG@TA NPs) were engineered with high-performance amplified oxidative damage and gene therapy effect for synergistic anti-tumor treatment. Cu2+ was converted into Cu + by redox reactions to deplete GSH while H2O2 was catalyzed to generate hydroxyl radicals (·OH). As a result, the ROS level was evidently improved. Moreover, controllable-released TH588 prevented MTH1-mediated DNA repairing, thus aggravated oxidative damage to tumor cells. Meanwhile, the released functional nucleic acid G3139 downregulated the expression of Bcl-2, and accelerated the apoptosis of tumor cells. In conclusion, the HTCG@TA demonstrated significant effect in oxidative damage amplification and tumor inhibition both in vitro and in vivo, which has provided a new outlook for the clinical application of chemo-dynamic tumor treatment and synergistic gene therapy with self-delivery nanoplatforms.http://www.sciencedirect.com/science/article/pii/S2452199X24004936Chemo-dynamic therapyOxidative damage amplifierG3139MTH1 inhibitorTH588Cancer therapy
spellingShingle Cui Ren
Zhiyong Shi
Xiaowen Zhang
Xueer Yu
Yang Gao
Zhi Qi
Yu Chen
Yong Wang
DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapy
Bioactive Materials
Chemo-dynamic therapy
Oxidative damage amplifier
G3139
MTH1 inhibitor
TH588
Cancer therapy
title DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapy
title_full DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapy
title_fullStr DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapy
title_full_unstemmed DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapy
title_short DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapy
title_sort dna mediated self assembly oxidative damage amplifier combined with copper and mth1 inhibitor for cancer therapy
topic Chemo-dynamic therapy
Oxidative damage amplifier
G3139
MTH1 inhibitor
TH588
Cancer therapy
url http://www.sciencedirect.com/science/article/pii/S2452199X24004936
work_keys_str_mv AT cuiren dnamediatedselfassemblyoxidativedamageamplifiercombinedwithcopperandmth1inhibitorforcancertherapy
AT zhiyongshi dnamediatedselfassemblyoxidativedamageamplifiercombinedwithcopperandmth1inhibitorforcancertherapy
AT xiaowenzhang dnamediatedselfassemblyoxidativedamageamplifiercombinedwithcopperandmth1inhibitorforcancertherapy
AT xueeryu dnamediatedselfassemblyoxidativedamageamplifiercombinedwithcopperandmth1inhibitorforcancertherapy
AT yanggao dnamediatedselfassemblyoxidativedamageamplifiercombinedwithcopperandmth1inhibitorforcancertherapy
AT zhiqi dnamediatedselfassemblyoxidativedamageamplifiercombinedwithcopperandmth1inhibitorforcancertherapy
AT yuchen dnamediatedselfassemblyoxidativedamageamplifiercombinedwithcopperandmth1inhibitorforcancertherapy
AT yongwang dnamediatedselfassemblyoxidativedamageamplifiercombinedwithcopperandmth1inhibitorforcancertherapy